AP
BLUE

AlpInvest Partners’s bluebird bio BLUE Stock Holding History

AlpInvest Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,079
Closed -$605K – 17
2016
Q2 		$605K Sell
1,079
-2,493
-70% -$1.41M 1.2% 18
2016
Q1 		$1.97M Hold
3,572
– – 3.75% 6
2015
Q4 		$2.97M Hold
3,572
– – 4.94% 6
2015
Q3 		$3.96M Buy
3,572
+1,080
+43% +$1.97M 7.79% 6
2015
Q2 		$5.44M Buy
+2,492
New +$5.08M 6.88% 6
2014
Q4 		– Sell
-1,817
Closed -$845K – 18
2014
Q3 		$845K Buy
+1,817
New +$838K 2.63% 10

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AlpInvest Partners's BLUE Position: Q3 2016 in Review

AlpInvest Partners sold out of bluebird bio (BLUE) in Q3 2016, closing a stake of 1,079 shares — an estimated $605K sold.

AlpInvest Partners first reported a position in BLUE in Q3 2014 and held it in 6 quarters. The position peaked at $5.44M in Q2 2015. 200 funds tracked by Wall St. Rank hold BLUE as of Q3 2016.

  • AlpInvest Partners reported no remaining bluebird bio position as of Q3 2016 after selling out during the quarter.
  • AlpInvest Partners sold 1,079 bluebird bio shares in Q3 2016, an estimated $605K.
  • AlpInvest Partners first reported a position in bluebird bio in Q3 2014 and held it in 6 quarters.
  • AlpInvest Partners's bluebird bio position peaked at $5.44M in Q2 2015.
  • 200 funds tracked by Wall St. Rank held bluebird bio as of Q3 2016.

Based on AlpInvest Partners's 13F filing for Q3 2016, filed 14 Nov 2016.